CredoScientia - Bibliothèque

Laparoscopic Extended Left Hepatectomy and Portal Vein Thrombectomy for Advanced Hepatocellular Carcinoma After Second-Line Conversion Therapy.

BACKGROUND: Hepatocellular carcinoma with portal vein tumor thrombus (HCC-PVTT) is correlated with poor prognosis. Recent advances in first-line therapies have enabled some patients with HCC-PVTT to b…

Thérapies de Conversion

Tan, W., Wei, J., Luo, X., Zhong, J., Zhou, R., Chen, Y., & Shang, C. (2026). Laparoscopic Extended Left Hepatectomy and Portal Vein Thrombectomy for Advanced Hepatocellular Carcinoma After Second-Line Conversion Therapy.. Ann Surg Oncol. https://doi.org/10.1245/s10434-026-19664-4

19/04/2026 Lire →

Neoadjuvant or conversion therapy nullifies the prognostic impact of surgical margin width in hepatocellular carcinoma: a single-center retrospective study.

BACKGROUND: The prognostic role of surgical margin width in hepatocellular carcinoma (HCC) patients undergoing hepatectomy after neoadjuvant or conversion therapy remains unclear. MATERIALS AND METHOD…

Thérapies de Conversion

Xie, H., Liao, Y., Liang, T., Huang, H., Wei, Y., Yang, K., Qin, C., Chen, M., Song, J., Zhou, X., Zhou, Y., Yang, C., Liao, X., Su, H., Zhu, G., Peng, M., Han, C., & Peng's, T. (2026). Neoadjuvant or conversion therapy nullifies the prognostic impact of surgical margin width in hepatocellular carcinoma: a single-center retrospective study.. BMC Surg. https://doi.org/10.1186/s12893-026-03752-z

18/04/2026 Lire →

[Conversion therapy for hepatoid adenocarcinoma of the stomach: A case report].

Hepatoid adenocarcinoma of the stomach (HAS) is a rare and highly malignant variant of gastric cancer, distinguished by histological features resembling hepatocellular carcinoma and frequent elevation…

Thérapies de Conversion

Li, J., Chen, L., Tang, J., Wu, Y., & Wang, A. (2026). [Conversion therapy for hepatoid adenocarcinoma of the stomach: A case report].. Beijing Da Xue Xue Bao Yi Xue Ban, 58(2), 399-404. https://doi.org/10.19723/j.issn.1671-167X.2026.02.027

18/04/2026 Lire →

Sequential Portal Vein Ligation and Robotic-Assisted Hepatectomy Following Conversion Therapy for Initially Unresectable Hepatocellular Carcinoma.

The goal of this protocol is to present a comprehensive multimodal approach for treating hepatocellular carcinoma (HCC) that is initially considered unresectable due to insufficient future liver remna…

Thérapies de Conversion

Guo, Y., Huang, J., Luo, M., Bi, J., Bao, S., & Zhang, Y. (2026). Sequential Portal Vein Ligation and Robotic-Assisted Hepatectomy Following Conversion Therapy for Initially Unresectable Hepatocellular Carcinoma.. J Vis Exp. https://doi.org/10.3791/69842

03/04/2026 Lire →

Oncological Outcomes Following Different TACE-Based Conversion Therapies for Intermediate-Advanced Hepatocellular Carcinoma.

BACKGROUND: Transcatheter arterial chemoembolization (TACE) is widely used for intermediate-advanced hepatocellular carcinoma (HCC). The efficacy and safety of TACE combined with systemic treatments a…

Thérapies de Conversion

Xu, H., Liu, Y., Zhang, H., Wu, H., Li, B., Chen, K., & Wei, Y. (2026). Oncological Outcomes Following Different TACE-Based Conversion Therapies for Intermediate-Advanced Hepatocellular Carcinoma.. Cancer Med, 15(4), e71867. https://doi.org/10.1002/cam4.71867

01/04/2026 Lire →

Conversion therapy: US Supreme Court rules against law banning practice for minors.

Thérapies de Conversion

Taylor, L. (2026). Conversion therapy: US Supreme Court rules against law banning practice for minors.. BMJ, 393, s637. https://doi.org/10.1136/bmj.s637

01/04/2026 Lire →

Cadonilimab Plus Lenvatinib Combined with Stereotactic Body Radiotherapy for Conversion Therapy in Unresectable or Potentially Resectable Hepatocellular Carcinoma: A Study Protocol.

BACKGROUND: Conversion therapy offers a critical opportunity to convert potentially resectable hepatocellular carcinoma (HCC) to surgically resectable status; yet, its optimal protocol and efficacy re…

Thérapies de Conversion

Fu, J. J., Zhang, J. F., Liu, D. E., Lin, Z. Y., Liu, H. L., Hu, J. L., Zhang, T., Tang, J., & Xue, J. (2026). Cadonilimab Plus Lenvatinib Combined with Stereotactic Body Radiotherapy for Conversion Therapy in Unresectable or Potentially Resectable Hepatocellular Carcinoma: A Study Protocol.. Curr Med Sci, 46(2), 563-572. https://doi.org/10.1007/s11596-026-00180-1

01/04/2026 Lire →

[Effect of conversion therapy and prognostic factors in patients with advanced intrahepatic cholangiocarcinoma: a real-world study].

To investigate the effect of gemcitabine plus cisplatin (GC) chemotherapy combined with immunotherapy in patients with unresectable intrahepatic cholangiocarcinoma (ICC) and its prognostic factors. …

Thérapies de Conversion

Liu, J. W., Liang, K., Lin, Y. X., Shen, F., & Wang, K. (2026). [Effect of conversion therapy and prognostic factors in patients with advanced intrahepatic cholangiocarcinoma: a real-world study].. Zhonghua Wai Ke Za Zhi, 64(4), 337-348. https://doi.org/10.3760/cma.j.cn112139-20251030-00503

01/04/2026 Lire →

Exploratory case series of conversion to carbon ion radiotherapy after systemic therapy in advanced hepatocellular carcinoma.

UNLABELLED: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality, with advanced cases often presenting macrovascular invasion (MVI) or extrahepatic spread (EHS), limiting cura…

Thérapies de Conversion

Anzai, H., Miwa, C., Ogasawara, S., Fujiya, M., Kurosaki, H., Tsuchiya, T., Yoshino, R., Katayama, K., Sawada, M., Akatsuka, T., Izai, R., Yonemoto, T., Yumita, S., Koroki, K., Inoue, M., Nakamura, M., Kanogawa, N., Nakamoto, S., Makishima, H., … Kato, J. (2026). Exploratory case series of conversion to carbon ion radiotherapy after systemic therapy in advanced hepatocellular carcinoma.. Int Cancer Conf J, 15(2), 195-202. https://doi.org/10.1007/s13691-025-00839-x

01/04/2026 Lire →

[The perioperative safety analysis of conversion therapy for liver cancer: a single-center retrospective study].

To investigate the perioperative safety of patients with hepatocellular carcinoma (HCC) undergoing conversion therapy followed by sequential surgical resection. This study was designed as a retrospe…

Thérapies de Conversion

Wei, Z. W., & Cai, J. Q. (2026). [The perioperative safety analysis of conversion therapy for liver cancer: a single-center retrospective study].. Zhonghua Wai Ke Za Zhi, 64(4), 330-336. https://doi.org/10.3760/cma.j.cn112139-20250815-00404

01/04/2026 Lire →

Development and validation of a nomogram to predict surgical resection after conversion therapy in unresectable hepatocellular carcinoma.

OBJECTIVE: This study aimed to explore factors associated with the likelihood of surgical resection after triple-combination conversion therapy in patients with initially unresectable hepatocellular c…

Thérapies de Conversion

Su, Y., Liang, Y., Zhong, D., Chen, Y., Yan, H., Yang, Q., Wang, M., Leng, Z., & Huang, X. (2026). Development and validation of a nomogram to predict surgical resection after conversion therapy in unresectable hepatocellular carcinoma.. Eur J Radiol, 197, 112724. https://doi.org/10.1016/j.ejrad.2026.112724

01/04/2026 Lire →

Photodynamic therapy combined with radiofrequency ablation and systemic therapy for KRAS-mutant advanced low rectal cancer: A case report.

The overall incidence of colorectal cancer, particularly the lower part of the rectum normally known as low rectal cancer, is globally on the rise, accounting for approximately 10% of all new oncology…

Thérapies de Conversion

Liao, L., Li, Y., Liu, J., Li, Y., Ma, J., Qi, Y., Ma, J., & Chen, H. (2026). Photodynamic therapy combined with radiofrequency ablation and systemic therapy for KRAS-mutant advanced low rectal cancer: A case report.. Photodiagnosis Photodyn Ther, 58, 105387. https://doi.org/10.1016/j.pdpdt.2026.105387

01/04/2026 Lire →